Update on the role of C1GALT1 in cancer

Oncol Lett. 2022 Mar;23(3):97. doi: 10.3892/ol.2022.13217. Epub 2022 Jan 27.

Abstract

Cancer remains one of the most difficult diseases to treat. In the quest for early diagnoses to improve patient survival and prognosis, targeted therapies have become a hot research topic in recent years. Glycosylation is the most common posttranslational modification in mammalian cells. Core 1β1,3-galactosyltransferase (C1GALT1) is a key glycosyltransferase in the glycosylation process and is the key enzyme in the formation of the core 1 structure on which most complex and branched O-glycans are formed. A recent study reported that C1GALT1 was aberrantly expressed in tumors. In cancer cells, C1GALT1 is regulated by different factors. In the present review, the expression of C1GALT1 in different tumors and its possible molecular mechanisms of action are described and the role of C1GALT1 in cancer development is discussed.

Keywords: T-synthase; core 1β1,3-galactosyltransferase; glycan; glycosylation; glycosyltransferase.

Publication types

  • Review

Grants and funding

This project was supported by the Natural Science Foundation of Hunan Province (grant no. 2019JJ80022), the Clinical Medical Technology Innovation Guidance Project of Hunan Province Technology Innovation Guidance Program (grant no. 2018SK51503).